Toshihiro Uemura
Papers
2
Total Citations
22
H-Index
2
About
Dr. Toshihiro Uemura is a urologic oncologist whose research focuses on optimizing surgical and ablative treatments for kidney and prostate cancers. His work centers on comparative effectiveness in nephron-sparing therapies for renal cell carcinoma (RCC) and on refining risk stratification for high-risk prostate cancer. Dr. Uemura’s most cited study (19 citations) provides a critical head-to-head comparison of robot-assisted partial nephrectomy (RAPN) versus percutaneous cryoablation for T1 RCC, offering evidence to guide treatment selection based on oncological outcomes and renal function preservation. In prostate cancer, his analysis of factors predicting biochemical recurrence after radical prostatectomy in clinical T3 disease (3 citations) helps identify patients who may benefit from multimodal therapy. These contributions advance personalized surgical decision-making in urologic oncology. Dr. Uemura’s work is particularly valuable for clinicians navigating the balance between cancer control and quality of life, and his comparative studies fill important gaps in the literature on minimally invasive kidney cancer treatments.
Research Focus
Key Achievements
Top Papers
- 1
- 2